Highlights Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 03:44:43 06/03/26 pm AEDT			5-day change	1st Jan Change
0.4200 ^AUD	+1.20%		+13.51%	-2.33%

04/03	Daily Special: Island Pharmaceuticals, GenusPlus Group, Horizon Gold	FI
04/03	Island Pharmaceuticals Enters Agreement to Advance Galidesivir Approval, Shares Up 19%	MT

Highlights

04/03	Daily Special: Island Pharmaceuticals, GenusPlus Group, Horizon Gold	FI
04/03	Island Pharmaceuticals Enters Agreement to Advance Galidesivir Approval, Shares Up 19%	MT
25/02	Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
10/02	Island Pharmaceuticals Admits It Was Not Strictly in Compliance With ASX Listing Rules	MT
07/01	Island Pharmaceuticals Secures US Patent for Antiviral Drug Candidate; Shares Rise 12%	MT
05/01	Island Pharmaceuticals says FDA advises it requires additional time to finalise response to co's submission	RE
05/12	Island Pharmaceuticals Secures US Patent for Antiviral Drug; Shares Rise 7%	MT
04/12	Island Pharmaceuticals Limited Completes Additional FDA Submission to Optimise Galidesivir Development Program	CI
19/09/25	Island Pharmaceuticals says FDA grants co Type C meeting under galidesivir's open IND application	RE
19/09/25	Island Pharmaceuticals Says US FDA Grants Type-C Meeting Request	MT
01/09/25	Island Pharmaceuticals Lodges Request for Meeting with US FDA for Drug Candidate	MT
30/08/25	Island Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
17/07/25	Island Pharmaceuticals' Major Shareholder Increases Stake Via Exercise Option	MT
09/07/25	Island Pharmaceuticals Agrees to Acquire Antiviral Program; Shares Up 17%	MT
09/07/25	Island Pharmaceuticals announces purchase of Galidesivir antiviral program from Biocryst Pharmaceuticals	RE
27/02/25	Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI
11/12/24	ASX Small-Cap Stocks to Watch	MT
15/11/24	ASX Small-Cap Stocks to Watch	MT
11/09/24	Island Pharmaceuticals Signs Letteer of Intent to Acquire BioCryst's Antiviral Program	MT
29/08/24	Island Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI
07/08/24	Island Pharmaceuticals Advances Development of Phase Two Dengue Trial; Shares Jump 8%	MT
03/07/24	Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule	MT
08/05/24	Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%	MT
16/04/24	Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication	MT
26/02/24	Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI